Abstract
Several lines of evidence suggest that oxidative stress is one of the key pathogenic mechanisms of osteoporosis. We aimed to elucidate the bone protective effects of petunidin, one of the most common anthocyanidins, considering its potent antioxidative activity. Petunidin (>5 μg/mL) significantly inhibited osteoclastogenesis and downregulated c-fos, Nfatc1, Mmp9, Ctsk, and Dc-stamp mRNA expression in RAW264.7 cells. Conversely, petunidin (>16 μg/mL) stimulated mineralized matrix formation and gene expression of Bmp2 and Ocn, whereas it suppressed Mmp13, Mmp2, and Mmp9 mRNA expression and proteolytic activities of MMP13 and MMP9 in MC3T3-E1 cells. Micro-CT and bone histomorphometry analyses of sRANKL-induced osteopenic C57BL/6J mice showed that daily oral administration of petunidin (7.5 mg/kg/day) increased bone volume to tissue volume (BV/TV), trabecular thickness (Tb.Th), trabecular number (Tb.N), the ratio of osteoid volume to tissue volume (OV/TV), osteoid thickness (O.Th), the ratio of osteoid surface to bone surface (OS/BS), the ratio of osteoblast surface to bone surface (Ob.S/BS), and the number of osteoblast per unit of bone surface (N.Ob/BS), and decreased trabecular separation (Tb.Sp), the ratio of eroded surface to bone surface (ES/BS), the ratio of osteoclast surface to bone surface (Oc.S/BS), and number of osteoclast per unit of bone surface (N.Oc/BS), compared to untreated mice. Furthermore, histological sections of the femurs showed that oral administration of petunidin to sRANKL-induced osteopenic mice increased the size of osteoblasts located along the bone surface and the volume of osteoid was consistent with the in vitro osteoblast differentiation and MMP inhibition. These results suggest that petunidin is a promising natural agent to improve sRANKL-induced osteopenia in mice through increased osteoid formation, reflecting accelerated osteoblastogenesis, concomitant with suppressed bone resorption.
Highlights
Osteoporosis, characterized by a significant decrease in bone mass and deterioration of the skeletal architecture [1], is thought to be one of the chronic and lifestyle-related diseases
We investigated the effects of petunidin, a B-ring O-methylated derivative of delphinidin, on bone metabolism in vitro using mouse macrophage RAW 246.7 cells and preosteoblastic MC3T3-E1 cells, to examine osteoclastogenesis and osteoblastogenesis, respectively
In order to clarify this, we have examined the effects of pure delphinidin aglycone in our previous study and demonstrated that delphinidin aglycone itself exerted bone protective effects both in vitro and in vivo [14]
Summary
Osteoporosis, characterized by a significant decrease in bone mass and deterioration of the skeletal architecture [1], is thought to be one of the chronic and lifestyle-related diseases. Researchers have shown that increased oxidative stress was one of the key pathogenic mechanisms underlying both estrogen deficiency-induced [2,3,4] and age-related bone loss [5,6,7]. Several flavonoids, a subgroup of polyphenols including hesperidin, quercetin, and luteolin, have been shown to prevent bone loss in ovariectomized mice [10,11,12]. An anthocyanin-rich compound from blueberries, one of the flavonoids, was reported to be protective against bone loss in the ovariectomized rat model [13]. Our previous study revealed that delphinidin, one of the major anthocyanidins, markedly inhibited the osteoclastic differentiation of RAW264.7 cells through suppression of NF-κB, c-fos, and Nfatc, and prevented bone loss in osteoporotic mouse models [14]
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.